IP Library Granted Patent US 7,179,659
Granted Patent B2
US 7,179,659 · App. 10/115,721 · Granted Feb 20, 2007

Sensor surfaces for detecting analytes and methods of use

Assignee: Agilent Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,179,659
App. No.
10/115,721
Granted
Feb 20, 2007
Kind
B2
Abstract

The present invention provides a method for detecting an analyte, comprising providing a sensor comprising a substrate coated with a free electron metal, a matrix layer disposed on the free electron metal, the matrix layer comprising an organic compound, wherein the organic compound has a boronic acid complexing moiety and, a boronic acid moiety complexed to the boronic acid complexing moiety; and contacting the sensor with the analyte to elicit a response; and measuring the response thereby detecting the analyte.

Claims (86)

1. A method for detecting the interaction of a biological binding pair, said method comprising:

providing a sensor comprising a substrate coated with a free electron metal, a matrix layer disposed on said free electron metal, said matrix layer comprising an organic compound, wherein said organic compound has a boronic acid complexing moiety and, a boronic acid moiety complexed to said boronic acid complexing moiety, wherein said boronic acid moiety is conjugated to a first member of said biological binding pair;

contacting said sensor with a second member of said binding pair, under conditions allowing binding of said second member to said first member of said binding pair, wherein the binding of said second member to said first member elicits a detectable response; and

measuring said response, thereby detecting said interaction of said biological binding pair.

2. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said matrix is a self-assembled monolayer.

3. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said matrix is a mixed self-assembled monolayer.

4. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said free electron metal is a member selected from the group consisting of copper, silver, aluminum, platinum and gold.

5. The method for detecting the interaction of a biological binding pair of claim 4 , wherein said free electron metal is gold.

6. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said organic compound having said boronic acid complexing moiety is of the formula

X—R—Y  (I)

wherein:

X is an anchor group that forms a complex with said free-electron metal;

R is an optionally substituted alkylene group optionally interrupted by one or more members selected from the group consisting of a heteroatom, an amido group and combinations thereof; and

Y is a boronic acid complexing moiety.

7. The method for detecting the interaction of a biological binding pair of claim 6 , wherein said organic compound having said boronic acid complexing moiety is of the formula:

X(CH 2 ) n C(O)NHR′—(NSBI) m —Y  (IIa)

X(CH 2 ) n NHC(O)R′—(NSBI) m —Y  (IIb)

wherein n is an integer from about 1 to 5;

R′is an optionally substituted alkylene group optionally interrupted by a heteroatom;

NSBI is a nonspecific binding inhibitor;

m is 0 or 1; and

Y is a boronic acid complexing moiety.

8. The method for detecting the interaction of a biological binding pair of claim 7 , wherein R′ is an optionally substituted alkylene group, which is optionally interrupted by a heteroatom and which is at least about 8 carbon atoms in length.

9. The method for detecting the interaction of a biological binding pair of claim 7 , wherein R′ 0 is an optionally substituted alkylene group, which is optionally interrupted by a heteroatom and which is between about 8 carbon atoms to about 40 carbon atoms in length.

10. The method for detecting the interaction of a biological binding pair of claim 7 , wherein m is 1.

11. The method for detecting the interaction of a biological binding pair of claim 7 , wherein Y has the formula:

wherein:

W is a member selected from the group consisting of H, OH, NH 2 , NHCH 3 , NHOH and NHOCH 3;

Q is a member selected from the group consisting of O, S and NH;

X is a member selected from the group consisting of H or OH; and

p is 0 to 3.

12. The method for detecting the interaction of a biological binding pair of claim 11 , wherein said organic compound having said boronic acid complexing moiety is of the formula

HS(CH 2 ) n C(O)NHR′—(NSBI)—SHA  (IV)

wherein:

n is an integer from 1 to about 5;

R′ is an optionally substituted alkylene group, which is optionally interrupted by a heteroatom;

NSBI is a nonspecific binding inhibitor;

x is 0 or 1; and

SHA is a salicylhydroxamic acid.

13. The method for detecting the interaction of a biological binding pair of claim 12 , wherein R′is an optionally substituted alkylene group, which is optionally interrupted by a hetero atom and which is at least about 8 carbon atoms in length.

14. The method for detecting the interaction of a biological binding pair of claim 12 , wherein R′is an optionally substituted alkylene group, which is optionally interrupted by a heteroatom and which is between about 8 carbon atoms to about 40 carbon atoms in length.

15. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said matrix comprises an organic compound of the formula:

X—(CH 2 ) n C(O)NHR′—(NSBI) m —Z  (VIa)

X—(CH 2 ) n C(O)NHR′—(NSBI) m —Z  (VIb)

wherein:

n is an integer from 1 to about 5;

R′ is an optionally substituted alkylene group, which is optionally interrupted by a heteroatom;

NSB is a nonspecific binding inhibitor;

m is 0 or 1; and

Z is an unreactive, uncharged chain-terminating group.

16. The method for detecting the interaction of a biological binding pair of claim 15 , wherein said nonspecific binding inhibitor is a member selected from the group consisting of an oligo(ethylene glycol), a poly(ethylene glycol), a branched OEG, a branched PEG, an oligo(peptide), an oligo(propylene sulfoxide), a sugar, a sugar alcohol, and a dendrimer.

17. The method for detecting the interaction of a biological binding pair of claim 15 , wherein Z is a member selected from the group consisting of H, CH 3 , OH, OCH 3 , CO 2 CH 3 , C(O)NH 2 , C(O)NHCH 3 , C(O)N(CH 3 ) 2 or SO 2 NH 2 .

18. The method for detecting the interaction of a biological binding pair of claim 15 , wherein said matrix layer comprises a combination of polymers having the formula:

—SCH 2 C(O)NH(CH 2 ) 11 (OCH 2 CH 2 ) 11 OC(O)Y(Polymer A) ; and —SCH 2 C(O)NH—(CH 2 ) 11 (OCH 2 CH 2 ) 3 OH (Polymer B), wherein Y is a boronic acid complexing moiety.

19. The method for detecting the interaction of a biological binding pair of claim 18 , wherein the mole percent of Polymer A is less than about 10% of the total mole percent of Polymer A and Polymer B.

20. The method for detecting the interaction of a biological binding pair of claim 18 , wherein the mole percent of the Polymer A is less than about 5% of the total mole percent of Polymer A and Polymer B.

21. The method for detecting the interaction of a biological binding pair of claim 15 , wherein R′ is an optionally substituted alkylene group, which is optionally interrupted by a heteroatom and which is at least about 8 carbon atoms in length.

22. The method for detecting the interaction of a biological binding pair of claim 15 , wherein R′ is an optionally substituted alkylene group, which is optionally interrupted by a heteroatom and which is between about 8 carbon atoms to about 40 carbon atoms in length.

23. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said second member of said binding pair is bound to said first member of said binding pair.

24. The method for detecting the interaction of a biological binding pair of claim 21 , wherein said first member of said biological binding pair comprises a bioactive species.

25. The method for detecting the interaction of a biological binding pair of claim 22 , wherein said boronic acid moiety is of the formula:

wherein:

BAS is a bioactive species;

Z 1 is a member selected from the group consisting of a saturated or unsaturated aliphatic chain up to about 0 to 6 carbon equivalents in length, an unbranched saturated or unsaturated aliphatic chain of from about 6 to 18 carbon equivalents in length with at least one intermediate amide or disulfide moiety, and a polyethylene glycol chain of from about 3 to 12 carbon equivalents in length;

Q 1 is a member selected from the group consisting of an amide, methyl amide, methylene, ether, thioether, methylene ether and methylene thioether moieties; and

t is an integer from 1 to about 3.

26. The method for detecting the interaction of a biological binding pair of claim 25 , wherein said BAS is a member selected from the group consisting of a protein, a polypeptide, a polypeptide fragment, a nucleic acid, a carbohydrate, a receptor, a hormone, a toxin, a vesicle, a liposome and a cell.

27. The method for detecting the interaction of a biological binding pair of claim 26 , wherein said BAS is a protein.

28. The method for detecting the interaction of a biological binding pair of claim 27 , wherein said protein is selected from the group consisting of a capture protein, an antigen, an antibody, protein A, protein G, protein AIG, an enzyme, a lectin, and avidin.

29. The method for detecting the interaction of a biological binding pair of claim 25 , wherein said boronic acid moiety has the formula:

wherein:

BAS is a protein;

Z 1 is C 1 –C 4 alkylene; and

Q 1 is an amide.

30. The method for detecting the interaction of a biological binding pair of claim 25 , wherein said boronic acid moiety has the formula:

wherein:

BAS is a protein;

Z 1 is C 1 –C 4 alkylene; and

Q 1 is an amide.

31. The method for detecting the interaction of a biological binding pair of claim 25 , wherein said boronic acid moiety has the formula:

wherein:

BAS is a protein;

Z 1 is C 1 –C 4 alkylene; and

Q 1 is an amide.

32. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said sensor surface is an array of sensor surfaces.

33. The method for detecting the interaction of a biological binding pair of claim 1 , wherein said sensor surface is used in a surface plasmon resonance sensing or in a potentiometric sensing.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2007
From: PROLINX, INC.
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 018741/0305 →
RELEASE OF SECURITY INTEREST Recorded Sep 29, 2003
From: BANK OF AMERICA VENTURES; BA VENTURE PARTNERS IV., L.P.; TULLIS DICKERSON CAPITAL FOCUS II, L.P.
To: PROLINX, INC.
Reel/Frame 014624/0662 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 2, 2003
From: PROLINX, INC.
To: BANK OF AMERICA VENTURES; BA VENTURE PARTNERS IV; TULLIS DICKERSON CAPITAL FOCUS II, L.P.
Reel/Frame 013645/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2002
From: STOLOWITZ, MARK L.; WILEY, JEAN P.; LI, GUISHENG; LUND, KEVIN
To: PROLINX INCORPORATED
Reel/Frame 013072/0140 →
Continuity (5)
Provisional Application 6036079800 · Mar 1, 2002
Provisional Application 6028109400 · Apr 2, 2001
Provisional Application 6028109300 · Apr 2, 2001
Provisional Application 6028108500 · Apr 2, 2001
Related Publication 20030032202A1 · Feb 13, 2003